About GenePOC Diagnostics
GenePOC Diagnostics is a company based in Quebec City (Canada) founded in 2007 was acquired by Meridian Bioscience in April 2019. GenePOC Diagnostics operates in a competitive market with competitors including Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
- Headquarter Quebec City, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Meridian Bioscience
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Meridian Bioscience
(Apr 30, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GenePOC Diagnostics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2016 | Amount | Series B - GenePOC Diagnostics | Valuation |
investors |
|
| Jan, 2015 | Amount | Series A - GenePOC Diagnostics | Valuation |
investors |
Investors in GenePOC Diagnostics
GenePOC Diagnostics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Meridian Bioscience, Debiopharm and Credit Mutuel Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and VC investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs
|
Founded Year | Domain | Location | |
|
Molecular diagnostic device and kits
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenePOC Diagnostics
Financial Statements - GenePOC Diagnostics
Genepoc Diagnostics Comparisons
Competitors of GenePOC Diagnostics
GenePOC Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Food safety technologies are provided for pathogen identification.
|
|
| domain | founded_year | HQ Location |
Viral infection treatments are developed using nucleic acid hybrid chemistry.
|
Frequently Asked Questions about GenePOC Diagnostics
GenePOC Diagnostics was founded in 2007 and raised its 1st funding round 8 years after it was founded.
GenePOC Diagnostics is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
GenePOC Diagnostics was founded in 2007 in Quebec City, Canada, within the diagnostics sector. Rapid nucleic acid assays for infectious diseases are created for point-of-care use. An automated device is employed, in which a small patient sample is loaded onto a cartridge and inserted into a reader for digital results within one hour. Development focuses on tests for STDs, hospital-acquired infections, respiratory conditions, neonatal sepsis, and gastrointestinal infections.
GenePOC Diagnostics's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
GenePOC Diagnostics has 3 investors. Key investors include Meridian Bioscience, Debiopharm, and Credit Mutuel Equity.